We are proud to share our latest study in Cancer Medicine Journal

We are proud to share our latest study in Cancer Medicine journal led by our partner IEO Istituto Europeo di Oncologia: “The impact of decision tools during oncological consultation with lung cancer patients: A systematic review”.

To date, lung cancer is one of the most lethal diagnoses worldwide. A variety of lung cancer treatments and modalities are available, which are generally presented during the patient and doctor consultation. The implementation of decision tools to facilitate patient’s decision-making and the management of their healthcare process during medical consultation is fundamental. Studies have demonstrated that decision tools are helpful to promote health management and decision-making of lung cancer patients during consultations. The main aim of the present work within the I3LUNG project is to systematically review the implementation of decision tools to facilitate medical consultation about oncological treatments for lung cancer patients.

For more information about I3LUNG, visit the Project website or contact us.

Read the Cancer Medicine article!

Stay tuned for more information and don’t forget to follow us on our social networks:

LinkedIn | Twitter | Instagram | Facebook

Share on: